AMANDA DAVIS: Open Payments
NPI 1861136897 · OTTUMWA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 25 payments from 13 companies in 2025. Trend: 2023 $751 · 2024 $390 · 2025 $954
Food & beverage: $610Travel & lodging: $209Education: $135
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $553 |
| Astellas Pharma US Inc | 2 | $115 |
| TOLMAR, INC. | 2 | $47 |
| PFIZER INC. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| 180 Medical, Inc. | 1 | $28 |
| Organogenesis Inc. | 1 | $27 |
| UCB, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: INTERSTIM, XTANDI, GEMTESA, ELIGARD, GENTLECATH, PURAPLY WOUND MATRIX, Bimzelx, ERLEADA.
Industry payments across IA — which companies pay providers there.
